Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Erythropoietin attenuates apoptosis after ischemia-reperfusion-induced renal injury in transiently hyperglycemic Wister rats.
Caetano AM, Vianna Filho PT, Castiglia YM, Golim MA, de Souza AV, de Carvalho LR, Deffune E, de Oliveira C, Vianna PT.
Transplant Proc. 2011 Dec;43(10):3618-21.
Related citations
Anemia treatment with erythropoietin in pregnant renal recipients.
Cyganek A, Pietrzak B, Kociszewska-Najman B, Sanko-Resmer J, Paczek L, Wielgos M.
Transplant Proc. 2011 Oct;43(8):2970-2.
Association between gene polymorphisms of the components of the renin-angiotensin-aldosteron system, graft function, and the prevalence of hypertension, anemia, and erythrocytosis after kidney transplantation.
Kujawa-Szewieczek A, Kolonko A, Kocierz M, Szotowska M, Trusolt W, Karkoszka H, Gumprecht J, Chudek J, Więcek A.
Transplant Proc. 2011 Oct;43(8):2957-63.
Contribution of anemia and hypertension to left ventricular hypertrophy during the initial 2 years after renal transplantation.
Ibernon M, Moreso F, Ruiz-Majoral A, Sarrias X, Sarrias M, Grinyó JM, Serón D.
Transplant Proc. 2011 Jul-Aug;43(6):2199-204.
Posttransplantation anemia: relationship with inflammatory markers, oxidation, and prohepcidin levels.
Sancho A, Pastor MC, Cañas L, Morales Indiano C, Ardèvol M, Aguerrevere S, Juega J, Romero R, Lauzurica R.
Transplant Proc. 2011 Jul-Aug;43(6):2196-8.
Evolution of glomerular filtration rate, renal injury markers, anemia, and angiotensin blockers use after change from calcineurin inhibitors to sirolimus in transplant patients with neoplasia versus chronic allograft nephropathy.
Luna E, Cerezo I, Macias R, Villa J, Martinez C, Cubero J, Martinez R, Ferreira F, García C.
Transplant Proc. 2011 Jul-Aug;43(6):2187-90.
End-stage liver cirrhosis with severe autoimmune hemolytic anemia, treated by blood type-incompatible living donor liver transplantation: a case report.
Sanefuji K, Ikegami T, Nagata S, Sugimachi K, Gion T, Uchiyama H, Soejima Y, Taketomi A, Shirabe K, Maehara Y.
Transplant Proc. 2011 Jun;43(5):2087-9.
Impact on health-related quality of life in kidney transplant recipients with late posttransplant anemia administered darbepoetin alfa: results from the STRATA study.
Bloom RD, Bolin P, Gandra SR, Scarlata D, Petersen J.
Transplant Proc. 2011 Jun;43(5):1593-600.
Proteinuria is a predictor of posttransplant anemia.
Bonofiglio R, Lofaro D, Greco R, Senatore M, Papalia T.
Transplant Proc. 2011 May;43(4):1063-6.
Diagnosis and classification of hemolytic uremic syndrome: the Hungarian experience.
Reusz GS, Szabó AJ, Réti M, Györke Z, Szilágyi Á, Farkas P, Prohászka Z.
Transplant Proc. 2011 May;43(4):1247-9.
Increasing levels of hemoglobin improve renal transplantation outcomes.
Lofaro D, Greco R, Papalia T, Bonofiglio R.
Transplant Proc. 2011 May;43(4):1036-8.
Avascular osteonecrosis and accompanying anemia, leucocytosis, and decreased bone mineral density in renal transplant recipients.
Paydas S, Balal M, Demir E, Sertdemir Y, Erken U.
Transplant Proc. 2011 Apr;43(3):863-6.
Risk factors for immediate anemia in renal transplant recipients: a single-center experience.
Rostami Z, Shafighi N, Baghersad MM, Einollahi B.
Transplant Proc. 2011 Mar;43(2):581-3.
Anemia after kidney transplantation in adult recipients: prevalence and risk factors.
Einollahi B, Lessan-Pezeshki M, Rostami Z, Kalantar E, Afshar R, Beiraghdar F.
Transplant Proc. 2011 Mar;43(2):578-80.
Anemia in heart and kidney allograft recipients: is there a role for hepcidin?
Przybylowski P, Malyszko J, Malyszko JS, Koc-Zorawska E, Sadowski J, Mysliwiec M.
Transplant Proc. 2010 Dec;42(10):4255-8.
Eculizumab: safety and efficacy after 17 months of treatment in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome: case report.
Châtelet V, Lobbedez T, Frémeaux-Bacchi V, Ficheux M, Ryckelynck JP, Hurault de Ligny B.
Transplant Proc. 2010 Dec;42(10):4353-5.
Prevalence and predictive factors of anemia after renal transplantation: a Moroccan report.
Radoui A, Skalli Z, Haddiya I, Benamar L, Ezzaitouni F, Ouzeddoun N, Bayahia R, Rhou H.
Transplant Proc. 2010 Nov;42(9):3542-9.
A prospective protocol-based trial of darbepoetin alfa therapy to correct the early anemia following renal transplantation.
Pankewycz O, Kulaylat M, Fagan L, Matthews B, Kohli R, Laftavi MR.
Transplant Proc. 2010 Nov;42(9):3537-41.
Erythropoietin resistance as surrogate marker of graft and patient survival in renal transplantation: 3-year prospective multicenter study.
Gomez-Alamillo C, Fernández-Fresnedo G, Ortega F, Campistol JM, Gentil MA, Arias M; Investigators of ARES Study.
Transplant Proc. 2010 Oct;42(8):2935-7.
Anemia control in kidney transplant patients treated with methoxy polyethylene glycol-epoetin beta (mircera): the Anemiatrans Group.
Sánchez-Fructuoso A, Guirado L, Ruiz JC, Torregrosa V, González E, Suárez ML, Gallego R; AnemiaTrans Study Group.
Transplant Proc. 2010 Oct;42(8):2931-4.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on